checkAd

     425  0 Kommentare PHARMAGEST INTERACTIVE announces its participation in the 14th edition of the « Large and Midcap Event » in Paris

    Pharmagest shares are eligible for the Equity Savings Plan

    The PHARMAGEST Group will be meeting investors at the 14th edition of the Paris Large and Midcap Event on 2 and 3 October, 2014 at the Palais Brongniart.

    The PHARMAGEST Group is the French leader in computer systems for pharmacies, with a 43.5 % share of the market, 9,800 clients and more than 750 employees. Since September 2007, the PHARMAGEST Group has also been present in Northern Europe with a 12 % market share in Belgium and Luxembourg through its subsidiary SABCO.

    As a privileged partner to pharmacists for almost 30 years now, the PHARMAGEST Group designs innovative computer solutions for pharmacies and is developing a high potential E-Business E-Media activity intended for pharmaceutical laboratories.

    The PHARMAGEST Group is also developing previously unpublished software solutions for Retirement Homes, (Care Homes and day centers for the elderly), through its subsidiary MALTA INFORMATIQUE.

    The first Logiciel de Gestion à Portail Intégré (Integrated Portal Management Software - LGPI Global Services®), creator of value for the patient, pharmacist and laboratory, dynamizes sales, optimizes purchases and enriches advice to the patient. It is also the first permanent impact medium for pharmacies, supplying laboratories with direct communication towards the pharmacist and his patients.

    At the heart of the digital revolution that is gradually establishing itself in the daily life of health professionals and patients alike, at the beginning of 2012, the PHARMAGEST Group created an e-Health business, bringing together the subsidiaries DIATELIC (expert systems), DOMEDIC EUROPE (intelligent pill dispenser DO-Pill SecuRTM) and KAPELSE (electronic health devices), structurally reinforced by the obtaining of several approvals for hosting health data.

    Financial calendar:

    • Publication of Q3 Turnover on 13 November 2014.

    Find out the latest news from the group at www.pharmagest.com

    Listed on the NYSE Euronext Paris(TM) - Compartment B
    Indices CAC ® SMALL90 and CAC ® All-Tradable by inclusion
    ISIN: FR 0000077687 - Reuters: PHA.PA - Bloomberg: - PMGI FP
    Pharmagest shares are eligible for the Equity Savings Plan

    Chairman of the Board of Directors:
    Thierry CHAPUSOT

    Managing Director:
    Dominique PAUTRAT
    Tel. 03 83 15 90 67 - dominique.pautrat@pharmagest.com

    Analysts and Investor Relations:
    Administrative and Financial Director: Jean-Yves SAMSON
    Tel. 03 83 15 90 67 - jean-yves.samson@pharmagest.com

    Press Relations:
    FIN'EXTENSO - Isabelle APRILE
    Tel. 01 39 97 61 22 - i.aprile@finextenso.fr




    This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: PHARMAGEST INTERACTIVE via Globenewswire

    HUG#1856952



    GlobeNewswire
    0 Follower
    Autor folgen
    Verfasst von GlobeNewswire
    PHARMAGEST INTERACTIVE announces its participation in the 14th edition of the « Large and Midcap Event » in Paris Pharmagest shares are eligible for the Equity Savings Plan The PHARMAGEST Group will be meeting investors at the 14th edition of the Paris Large and Midcap Event on 2 and 3 October, 2014 at the Palais Brongniart. The PHARMAGEST Group is the …